Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2716891 | The American Journal of Medicine | 2010 | 4 Pages |
Abstract
Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ryan J. Fante, Vikram D. Durairaj, Scott C.N. Oliver,